Oncology & Cancer

Drug mechanism opens door for new anti-cancer immunotherapies

Researchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immune cell function, that could be exploited using new anti-cancer immunotherapies.

page 1 from 17